Previous close | 130.10 |
Open | 128.85 |
Bid | 127.55 x 0 |
Ask | 128.20 x 0 |
Day's range | 128.85 - 128.85 |
52-week range | 114.20 - 130.10 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 24 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered technology for pathology, today announced a multi-faceted collaboration designed to accelerate the adoption of digital and AI pathology innovations to improve quality, speed and efficiency in diagnosing cancer and other diseases.
A week ago, Quest Diagnostics Incorporated ( NYSE:DGX ) came out with a strong set of first-quarter numbers that could...
Comprehensive SWOT Analysis: Quest Diagnostics Inc's Financial and Strategic Position